Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Teachers Learn to Reinvent High School Biology

Acera School's teacher trainings link classroom lab activities to real-world research and innovations, like gene-editing with CRISPR.


News provided by

Acera

Feb 16, 2019, 15:00 ET

Share this article

Share toX

Share this article

Share toX

High school biology teacher Cleveish Bogle learns CRISPR technology to bring gene editing labs into her public school classroom.
High school biology teacher Cleveish Bogle learns CRISPR technology to bring gene editing labs into her public school classroom.

WINCHESTER, Mass., Feb. 16, 2019 /PRNewswire-PRWeb/ -- At Acera's Life Sciences Lab, as part of Acera's Education Innovation outreach program, biology teacher Cleveish Bogle is excited. The KIPP Academy Lynn Collegiate High School teacher is preparing a southern blot -- a procedure for identifying specific sequences of DNA -- and imagining her students' reaction to the lab exercise and to the new unit she will now add to her class in March. Her students will use CRISPR technology to edit genes in their high school biology lab exercises, and discuss how this new biotechnology changes future possible therapeutic treatment for disease.

"My students have been asking for more lab activities, and I think this is right on par with that," said Bogle. "It's investigative, it's hands-on, and they get to really dive deep into the things we've been talking about in class and see it in practice. They will love this."

Investing in STEM programs paves the way for the next generation of scientists, who may one day be on the brink of their own ground-breaking discoveries.

Post this

Bogle is part of a cohort of public school teachers taking part in a free, three-day workshop series funded in part by Bristol-Myers Squibb and led by Acera: the Massachusetts School of Science, Creativity, and Leadership. Michael Hirsch, life sciences lab manager at the Winchester-based K-8 STEM school, is training the group on gene editing with CRISPR technology, using a curriculum he developed and pilot-tested at Acera.

"Bristol-Myers Squibb is proud to support this real-world learning opportunity for Acera School, and for students who are passionate about the life sciences," said Saurabh Saha, senior vice president and global head of translational medicine at Bristol-Myers Squibb. "As a science-driven organization, we are committed to investing in STEM programs to help pave the way for the next generation of scientists, who may one day be on the brink of their own ground-breaking discoveries."

The teachers hail from Greater Boston public schools, including those in Cambridge, Gloucester, Lynn, Littleton, Lexington, Lowell, and Salem. The series included a day at Novartis' Community Exploration and Learning Lab (CELL), where teachers learned how scientists today work iteratively in the lab to conduct research, and how to translate these innovations into lesson plans that align with Next Generation Science Standards and offer inspiration and a sense of purpose to students.

"All students should be able to link classroom learning to real world innovations," said Courtney Dickinson, founder and director of Acera. "Working with relevant technology that is in the news, and engaging in deep discussions to understand these innovations -- including how they work and why they matter -- makes science labs meaningful and enables students to see a pathway for themselves as future scientists and innovators."

Building this pathway can pay off in the future, as the U.S. currently doesn't have the workforce to fill its STEM positions. According to the Smithsonian Science Education Center, more than 2.4 million STEM jobs went unfilled in 2018. And with Boston recently ranked by WalletHub as one of the best metro areas for STEM jobs, Acera staff hope that introducing these new and innovative curricula at a younger age could spark local students' interest in these careers. To that end, life sciences leader Bristol Myers-Squibb recently invested $50,000 in Acera's Education Innovation Initiative to launch its curricula in public schools.

David Enos, a biotechnology teacher at Gloucester High School, sees the new activities as a way to boost confidence and interest in STEM among under-performing students. "With these hands-on elements, the kids who struggle academically can often just jump right in and do it," he said.

In addition to gene editing with CRISPR, Acera has a year-long, 11-unit "Reinventing High School Biology" curriculum covering cell cycles, microbiomes, ecology, and other areas of biology. The school's Education Innovation Initiative is partnering with STEM industry leaders to export this curriculum to public schools. Its next teacher training workshop series will take place this summer.

Founded in 2010, Acera engages students in individualized, project-based learning that is designed around their passions and aligned with their own abilities. In addition to K-8 education, Acera offers daily after-school enrichment programs as well as February, April, and summer vacation camps. For more information, visit aceraschool.org.

SOURCE Acera

Related Links

http://www.aceraschool.org

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.